CS
CELG

Candriam SCA’s Celgene Corp CELG Stock Holding History

Candriam SCA’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-762,400
Closed -$70.2M – 855
2019
Q2 		$70.2M Sell
762,400
-489,524
-39% -$46.5M 0.88% 19
2019
Q1 		$118M Sell
1,251,924
-859,400
-41% -$75.2M 1.51% 12
2018
Q4 		$135M Buy
2,111,324
+825,120
+64% +$60.9M 2.08% 4
2018
Q3 		$115M Buy
1,286,204
+170,225
+15% +$15M 1.53% 8
2018
Q2 		$88.6M Buy
1,115,979
+188,302
+20% +$15.6M 1.4% 8
2018
Q1 		$82.8M Buy
927,677
+170,146
+22% +$16.3M 1.41% 8
2017
Q4 		$79.1M Sell
757,531
-52,157
-6% -$5.89M 1.37% 7
2017
Q3 		$118M Sell
809,688
-19,598
-2% -$2.67M 2.06% 2
2017
Q2 		$108M Buy
829,286
+96,167
+13% +$11.8M 2.02% 2
2017
Q1 		$91.2M Buy
733,119
+365,647
+100% +$43.8M 1.77% 4
2016
Q4 		$42.5M Buy
367,472
+16,218
+5% +$1.81M 0.98% 13
2016
Q3 		$36.7M Sell
351,254
-88,808
-20% -$9.61M 0.88% 18
2016
Q2 		$43.4M Sell
440,062
-140,577
-24% -$14.5M 1.13% 14
2016
Q1 		$57.8M Sell
580,639
-78,061
-12% -$8.04M 1.45% 9
2015
Q4 		$78.9M Buy
658,700
+9,970
+2% +$1.15M 2.11% 5
2015
Q3 		$70.2M Buy
648,730
+41,548
+7% +$5.16M 1.72% 5
2015
Q2 		$70.3M Sell
607,182
-104,196
-15% -$11.9M 1.46% 7
2015
Q1 		$82M Sell
711,378
-44,170
-6% -$5.28M 1.65% 5
2014
Q4 		$84.5M Buy
+755,548
New +$79.7M 1.77% 1

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Candriam SCA's CELG Position: Q3 2019 in Review

Candriam SCA sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 762,400 shares — an estimated $70.2M sold.

Candriam SCA first reported a position in CELG in Q4 2014 and held it in 19 quarters. The position peaked at $135M in Q4 2018. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Candriam SCA reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Candriam SCA sold 762,400 Celgene Corp shares in Q3 2019, an estimated $70.2M.
  • Candriam SCA first reported a position in Celgene Corp in Q4 2014 and held it in 19 quarters.
  • Candriam SCA's Celgene Corp position peaked at $135M in Q4 2018.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Candriam SCA's 13F filing for Q3 2019, filed 21 Oct 2019.